Audenshaw Pharmacy Limited Filleted accounts for Companies House (small and micro)

AUDENSHAW PHARMACY LIMITED - Company Information

false false false false false false false false false true false false false false false false false No description of principal activity 2018-03-01 Sage Accounts Production Advanced 2018 Update 1 - FRS 35,000 35,000 44,220 40,431 758 41,189 3,031 3,789 xbrli:pure xbrli:shares iso4217:GBP 05295689 2018-03-01 2019-02-28 05295689 2019-02-28 05295689 2018-02-28 05295689 2017-03-01 2018-02-28 05295689 2018-02-28 05295689 core:NetGoodwill 2018-03-01 2019-02-28 05295689 core:FurnitureFittings 2018-03-01 2019-02-28 05295689 bus:RegisteredOffice 2018-03-01 2019-02-28 05295689 bus:LeadAgentIfApplicable 2018-03-01 2019-02-28 05295689 bus:Director1 2018-03-01 2019-02-28 05295689 bus:Director2 2018-03-01 2019-02-28 05295689 core:NetGoodwill 2019-02-28 05295689 core:FurnitureFittings 2018-02-28 05295689 core:FurnitureFittings 2019-02-28 05295689 core:WithinOneYear 2019-02-28 05295689 core:WithinOneYear 2018-02-28 05295689 core:ShareCapital 2019-02-28 05295689 core:ShareCapital 2018-02-28 05295689 core:RetainedEarningsAccumulatedLosses 2019-02-28 05295689 core:RetainedEarningsAccumulatedLosses 2018-02-28 05295689 core:FurnitureFittings 2018-02-28 05295689 bus:SmallEntities 2018-03-01 2019-02-28 05295689 bus:AuditExemptWithAccountantsReport 2018-03-01 2019-02-28 05295689 bus:FullAccounts 2018-03-01 2019-02-28 05295689 bus:SmallCompaniesRegimeForAccounts 2018-03-01 2019-02-28 05295689 bus:PrivateLimitedCompanyLtd 2018-03-01 2019-02-28 05295689 core:EntitiesControlledByKeyManagementPersonnel 2018-03-01 2019-02-28 05295689 core:EntitiesControlledByKeyManagementPersonnel 2019-02-28 05295689 core:EntitiesControlledByKeyManagementPersonnel 2018-02-28 05295689 1 2018-03-01 2019-02-28

COMPANY REGISTRATION NUMBER: 05295689

Audenshaw Pharmacy Limited

Filleted Unaudited Financial Statements

28 February 2019

Audenshaw Pharmacy Limited

Financial Statements

Year Ended 28 February 2019

Contents	Page

Officers and Professional Advisers	1

Statement of Financial Position	2

Notes to the Financial Statements	4

Audenshaw Pharmacy Limited

Officers and Professional Advisers

The Board of Directors	P R Mistry
	R P Mistry

Registered Office	3 Chapel Street
	Audenshaw
	Manchester
	M34 5DE

Accountants	Downham Mayer Clarke Limited
	Chartered Accountants
	41 Greek Street
	Stockport
	Cheshire
	SK3 8AX

Bankers	Santander
	Bridle Road
	Bootle
	Merseyside
	L30 4GB

Audenshaw Pharmacy Limited

Statement of Financial Position

28 February 2019

	2019		2018
Note	£	£	£

Fixed Assets

Tangible assets	6		3,031	3,789

Current Assets

Stocks		38,056	31,745
Debtors	7	1,575,120	1,539,838
Cash at bank and in hand		224,417	269,625
		------------	------------
		1,837,593	1,841,208

Creditors: amounts falling due within one year	8	252,001		319,214
		------------		------------
Net Current Assets			1,585,592	1,521,994
			------------	------------
Total Assets Less Current Liabilities			1,588,623	1,525,783

Provisions

Taxation including deferred tax	720	720
	------------	------------
Net Assets	1,587,903	1,525,063
	------------	------------

Capital and Reserves

Called up share capital	100	100
Profit and loss account	1,587,803	1,524,963
	------------	------------
Shareholder Funds	1,587,903	1,525,063
	------------	------------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 28 February 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Audenshaw Pharmacy Limited

Statement of Financial Position (continued)

28 February 2019

These financial statements were approved by the board of directors and authorised for issue on 22 November 2019 , and are signed on behalf of the board by:

P R Mistry

Director

Company registration number: 05295689

Audenshaw Pharmacy Limited

Notes to the Financial Statements

Year Ended 28 February 2019

1. General Information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 3 Chapel Street, Audenshaw, Manchester, M34 5DE.

2. Statement of Compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting Policies

Basis of Preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Judgements and Key Sources of Estimation Uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances .

Revenue Recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Income Tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

	Goodwill	-	20% straight line

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Tangible Assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

	Fixtures and Fittings	-	20% reducing balance

Impairment of Fixed Assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

Defined Contribution Plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

4. Employee Numbers

The average number of persons employed by the company during the year amounted to 15 (2018: 10 ).

5. Intangible Assets

	Goodwill
	£
Cost
At 1 March 2018 and 28 February 2019	35,000
	--------
Amortisation
At 1 March 2018 and 28 February 2019	35,000
	--------
Carrying amount
At 28 February 2019	–
	--------
At 28 February 2018	–
	--------

6. Tangible Assets

	Fixtures and fittings	Total
	£	£
Cost
At 1 March 2018 and 28 February 2019	44,220	44,220
	--------	--------
Depreciation
At 1 March 2018	40,431	40,431
Charge for the year	758	758
	--------	--------
At 28 February 2019	41,189	41,189
	--------	--------
Carrying amount
At 28 February 2019	3,031	3,031
	--------	--------
At 28 February 2018	3,789	3,789
	--------	--------

7. Debtors

	2019	2018
	£	£
Trade debtors	79,230	91,615
Amounts owed by group undertakings and undertakings in which the company has a participating interest	1,473,029	1,425,467
Other debtors	22,861	22,756
	------------	------------
	1,575,120	1,539,838
	------------	------------

8. Creditors: amounts falling due within one year

	2019	2018
	£	£
Trade creditors	154,521	154,213
Corporation tax	35,249	42,471
Social security and other taxes	662	737
Other creditors	61,569	121,793
	---------	---------
	252,001	319,214
	---------	---------

9. Directors' Advances, Credits and Guarantees

There were no directors advances, credits or guarantees in the current or previous year.

10. Related Party Transactions

During the year the company was owed £ 1,473,029 ( 2018 : £ 1,425,467 ) and dividends of £100,000 (2018 : £100,000) were paid to its parent company P & R Mistry Limited . The loans are interest free and repayable on demand.

11. Controlling Party

The company's ultimate parent company is P & R Mistry Limited , a company incorporated and registered in the UK.